Avantor, provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

RIM Bio's Changzhou, China, the facility is Avantor's first single-use production plant in the AMEA region, building on the company's existing global single-use manufacturing network in the Americas and Europe and greatly increasing capacity to meet growing global demand in bioprocessing. Avantor will leverage RIM Bio's proprietary technologies and best-in-class lead times to provide single-use customers with a differentiated offering.

Dr Ger Brophy, Executive Vice President, Biopharma Production at Avantor, said, "Adding RIM Bio enables Avantor to better serve our customers by expanding our single-use manufacturing, distribution, and cleanroom capabilities to the AMEA region. RIM serves as an anchor for us to build our presence in this key region, as we better position Avantor to capture long-term opportunities in the growing, global Bioproduction space."

This acquisition marks another major investment in China. In December 2019, the company opened its Shanghai Innovation & Customer Support centre, a dedicated bioprocessing facility focussed on research, application development and process optimization solutions for biopharma companies across AMEA.